April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Shannon Westin: Overall survival is improved in all comers in the RUBY study of Immunotherapy and chemotherapy in advanced/recurrent Endometrial Cancer
Mar 26, 2024, 09:45

Shannon Westin: Overall survival is improved in all comers in the RUBY study of Immunotherapy and chemotherapy in advanced/recurrent Endometrial Cancer

Shannon Westin, Professor at Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center, shared a post on X/Twitter:

Overall survival is improved in all comers in the RUBY study of Immunotherapy and chemotherapy in advanced/recurrent Endometrial Cancer – 31% reduction in risk of death consistent with 16 month improvement!!!

Source: Shannon Westin/X